Aug 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2023 Jun 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.57 2.79 13.50
(-7.8 pct) (-8.0 pct) (+12.1 pct)
Operating loss 290 mln loss 212 mln 390 mln
Recurring loss 288 mln loss 212 mln 400 mln
Net loss 215 mln loss 140 mln 250 mln
EPS loss 56.87 yen loss 37.21 yen 66.11 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T